Monitor the special meeting outcome on May 8. If the reverse split is approved, the board will set the ratio; failure to pass could trigger Nasdaq delisting proceedings. Also watch for any late proxy filings or further postponements.
Price Chart
Executive Summary
Lunai Bioworks postpones its special meeting from May 4 to May 8, 2026 to allow more time for broker discretionary voting on a reverse stock split proposal. The reverse split (range 1:3–1:30) is needed to meet Nasdaq continued listing requirements. The record date remains April 10, 2026; 36,271,119 shares outstanding.
Key Financial Metrics
Key Facts
- Special meeting postponed from May 4 to May 8, 2026 at 9:00 a.m. ET.
- Postponement due to timing issues with Broadridge proxy distribution; aims to secure broker discretionary votes under NYSE Rule 452.
- Proposal 1: Reverse stock split at ratio of 1-for-3 to 1-for-30, board discretion on exact ratio.
- Proposal 2: Adjournment proposal to allow additional solicitation if needed.
- Record date unchanged: April 10, 2026; 36,271,119 shares of common stock outstanding and entitled to vote.
- Virtual meeting at www.virtualshareholdermeeting.com/LNAI2026SM; voting deadline May 7, 2026 at 11:59 p.m. ET.
Financial Impact
No financial figures provided; reverse split is a non-financial corporate action.
Risk Factors
- Inability to obtain quorum at the postponed meeting.
- Broker discretionary votes may not be exercised as expected; NYSE may classify proposals as non-routine.
- If reverse split fails, Nasdaq may delist LNAI, leading to potential loss of liquidity and further dilution.
- Further postponements or adjournments could prolong uncertainty.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001731122-26-000622 |
| Document: 0001731122-26-000622-index-headers.html | 0001731122-26-000622 |
| Document: 0001731122-26-000622-index.html | 0001731122-26-000622 |
| Document: 0001731122-26-000622.txt | 0001731122-26-000622 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 27, 2026 today | EFFECT | $0.2510 | awaiting T+1 | — | $0.2500 (+0.40%) |
Oct 22, 2026 4d ago | 8-K | $0.2946 $0.2750 | ▲ +6.65% | ▲ +7.36% | $0.2500 (+15.14%) |
Oct 15, 2026 11d ago | SC 13D/A | $0.6800 $0.4720 | ▲ +30.59% | ▲ +31.01% | $0.2500 (+63.24%) |
Oct 9, 2026 17d ago | 8-K | $1.23 $1.11 | ▲ +9.76% | ▲ +9.70% | $0.2500 (+79.67%) |
Sep 29, 2026 27d ago | NT 10-K | $1.47 $1.38 | ▲ +6.12% | ▲ +6.30% | $0.2500 (+82.99%) |
Jun 17, 2026 18w ago | 8-K | $3.78 $4.15 | ▲ +9.79% | ▲ +10.10% | $0.2500 (−93.39%) |
Jun 16, 2026 18w ago | 8-K | $4.00 $3.78 | ▼ −5.50% | ▼ −6.28% | $0.2500 (−93.75%) |
May 20, 2026 22w ago | 8-K | $1.80 $2.32 | ▼ −28.89% | ▼ −28.69% | $0.2500 (+86.11%) |
May 1, 2026 25w ago | 8-K | $2.60 $2.50 | ▼ −3.88% | ▼ −4.68% | $0.2500 (−90.37%) |
Apr 28, 2026 25w ago | DEFA14A | $2.66 $2.64 | ▼ −0.90% | ▼ −1.92% | $0.2500 (−90.62%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers